iTeos Therapeutics, Inc. Rings the Opening Bell
ABOUT THIS EVENT
iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of highly differentiated immuno-oncology therapeutics for patients rang the Nasdaq Opening Bell remotely from across the country.
In honor of the occasion, Michel Detheux, President & CEO, rang the Opening Bell alongside the Company’s team in a virtual bell ringing ceremony.